Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib.
Sophia A Ederaine,
Carolyn J Kushner,
Jerry Shapiro,
Kristen I Lo Sicco
Case Report
JAAD case reports
2022
1 citações
PubMed
DOI
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'pmid\u003D35036501';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
Resumo Rápido
A 31-year-old woman with alopecia universalis is described that did not improve with oral tofacitinib plus adjuvant intralesional corticosteroids but responded significantly with the addition of PRP to oral to FACS, an autologous blood product thought to enhance hair growth and assist with cell repair.
Used In Evidence Reviews
Similar Papers
Journal of cosmetic dermatology · 2021
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
315 citations
Open Access
Stem cells translational medicine · 2015
The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial.
310 citations
Open Access
Clinical reviews in allergy & immunology · 2021
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
304 citations
Cells · 2019
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development.
287 citations
Open Access
The British journal of dermatology · 2013
A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.
279 citations
Journal of the European Academy of Dermatology and Venereology : JEADV · 2018
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.
248 citations
Open Access